Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. It is engaged in the research, development, production, marketing, and distribution of pharmaceutical products. The product portfolio of the company includes Active Pharmaceutical Ingredients (API), human formulations, animal health and veterinary, and consumer health and wellness products. Its products are marketed under brands like Amlodac, Inditel, Pivasta, and others. The company's operating segments are; Pharmaceuticals which derives key revenue, and Consumer products. Geographically, it generates maximum revenue from the United States followed by India, and other countries.
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Cadila Healthcare Ltd or scroll over to Cadila Healthcare Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Cadila Healthcare Ltd?
The share price of Cadila Healthcare Ltd stocks is ₹973.90 as on 22/12/2024
What is the Market Cap of Cadila Healthcare Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Cadila Healthcare Ltd stock is ₹97,997.1 Cr on 22/12/2024.
In which sector / industry does Cadila Healthcare Ltd operate?
Cadila Healthcare Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Cadila Healthcare Ltd?
The revenue of Cadila Healthcare Ltd as of 2023 was ₹19,021.5 Cr
What is the PE ratio of Cadila Healthcare Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Cadila Healthcare Ltd is
22.97 as on 22/12/2024.
What is the 52 week high price of Cadila Healthcare Ltd?
The 52 week high of Cadila Healthcare Ltd stock is ₹1,323.90.
What is the 52 week low price of Cadila Healthcare Ltd?
The 52 week low of Cadila Healthcare Ltd stock is ₹648.05.
Can fractional shares of Cadila Healthcare Ltd be purchased?
No, you cannot buy fractional shares of Cadila Healthcare Ltd, or any listed Indian company as of now.